Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity.
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2017 |
| Author/s |
author: Lynn A. Hyde John M Sanders Jack D Scott Ravi Nargund |
| Publication date | March 16, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |